What is AOTI Inc?
, together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide.
AOTI · Verdict
Solid reward · moderate risk
AOTI stands out on valuation and volatility, but watch the cash flow signal.
Based on 88% data coverage
AOTI · Verdict
P/E 12.6× · PEG 0.10
Top decile vs peers
Rev +303.4% CAGR · earnings +172.5%
Interest covered 0.5×
-13% free-cash-flow margin
-3% net margin · 14% ROE
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 58.36M, and a P/E ratio of 55.0x.
The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.